Autologous Cytokine Induced Killer Cells (CIK) for Patients With Severe Psoriasis

NCT01894373 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis
Adoptive Immunotherapy

Interventions

DRUG: Adoptive Immunotherapy
BIOLOGICAL: CIK

Sponsor

Chinese PLA General Hospital